Birch Hill Investment Advisors Lifted By $528,325 Its Pfizer (PFE) Position; Stellar Biotechnologies (SBOT) Shorts Down By 0.24%

August 12, 2018 - By Catherine Diaz

Stellar Biotechnologies, Inc. (NASDAQ:SBOT) Logo

Birch Hill Investment Advisors Llc increased Pfizer Inc (PFE) stake by 61.56% reported in 2018Q1 SEC filing. Birch Hill Investment Advisors Llc acquired 15,095 shares as Pfizer Inc (PFE)’s stock declined 3.80%. The Birch Hill Investment Advisors Llc holds 39,614 shares with $1.41 million value, up from 24,519 last quarter. Pfizer Inc now has $239.42B valuation. The stock decreased 0.17% or $0.07 during the last trading session, reaching $40.93. About 17.26M shares traded. Pfizer Inc. (NYSE:PFE) has risen 10.95% since August 12, 2017 and is uptrending. It has underperformed by 1.62% the S&P500. Some Historical PFE News: 19/03/2018 – Protalix BioTherapeutics Announces Acceptance of Abstract on OPRX-106 as a Lecture Presentation at the Digestive Diseases Week® 2018; 10/04/2018 – TISHMAN SPEYER SECURES ALL FINANCING TO BUILD $3.7 BLN 65-STORY OFFICE TOWER IN NEW YORK’S HUDSON YARDS; 29/05/2018 – PFIZER’S XALKORI® (CRIZOTINIB) GETS BREAKTHROUGH DESIGNATION IN; 17/05/2018 – FDA’S GOTTLIEB – COS FOR WHICH INQUIRIES HAVE BEEN RECEIVED INCLUDE DANCO LABORATORIES, ROXANE LABORATORIES, CORCEPT THERAPEUTICS, AEGERION PHARMA; 22/03/2018 – GSK advances in Pfizer consumer health auction as Reckitt quits; 04/05/2018 – Pneumococcal Infections: 2018 Pipeline Highlights – ResearchAndMarkets.com; 03/04/2018 – Pfizer signs deal with Allogene to develop cancer cell therapy; 17/05/2018 – PFIZER – POSITIVE TOP-LINE RESULTS OF PHASE 3 STUDY EXAMINING USE OF LYRICA ORAL SOLUTION CV AS ADJUNCTIVE THERAPY; 10/04/2018 – PFIZER INC – WILL CONDUCT ADDITIONAL ANALYSES ON DATA FROM AXITINIB STUDY; 15/03/2018 – Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market to Reach Over US$ 3

Stellar Biotechnologies Inc (NASDAQ:SBOT) had a decrease of 0.24% in short interest. SBOT’s SI was 125,400 shares in August as released by FINRA. Its down 0.24% from 125,700 shares previously. With 135,900 avg volume, 1 days are for Stellar Biotechnologies Inc (NASDAQ:SBOT)’s short sellers to cover SBOT’s short positions. The SI to Stellar Biotechnologies Inc’s float is 1.48%. The stock decreased 3.73% or $0.06 during the last trading session, reaching $1.42. About 53,704 shares traded. Stellar Biotechnologies, Inc. (NASDAQ:SBOT) has declined 76.80% since August 12, 2017 and is downtrending. It has underperformed by 89.37% the S&P500.

Stellar Biotechnologies, Inc., a biotechnology company, engages in the aquaculture, research and development, manufacture, and commercialization of keyhole limpet hemocyanin protein primarily in Europe, the United States, and Asia. The company has market cap of $6.70 million. It provides KLH, an immune-stimulating molecule used as an active pharmaceutical ingredient in various immunotherapies; and as an injectable product to assess immune response. It currently has negative earnings. The firm offers its KLH protein under the Stellar KLH brand.

Investors sentiment decreased to 0.89 in Q1 2018. Its down 0.17, from 1.06 in 2017Q4. It turned negative, as 70 investors sold PFE shares while 718 reduced holdings. 104 funds opened positions while 595 raised stakes. 4.01 billion shares or 1.39% less from 4.07 billion shares in 2017Q4 were reported. James Invest Rech Incorporated holds 0.94% in Pfizer Inc. (NYSE:PFE) or 703,236 shares. Meiji Yasuda Asset Mgmt Limited invested in 1.33% or 393,724 shares. Legal General Gp Public Limited Com owns 29.19M shares for 0.79% of their portfolio. Perigon Wealth Mgmt Limited Liability Corp accumulated 6,367 shares or 0.08% of the stock. Rand Wealth Ltd Liability Com holds 243,587 shares. Mirae Asset Global Investments has 1.08M shares. Blackrock holds 459.53M shares or 0.78% of its portfolio. Schaper Benz Wise Invest Counsel Wi has 1.19% invested in Pfizer Inc. (NYSE:PFE). Donaldson Capital Management Limited Liability holds 714,288 shares. First Bancorp Of Mount Dora Inv owns 120,196 shares or 1.96% of their US portfolio. First Heartland Consultants Inc holds 0.21% of its portfolio in Pfizer Inc. (NYSE:PFE) for 19,303 shares. Asset Mgmt One reported 9.84M shares. Mercer Advisers invested in 0.65% or 24,897 shares. Park National Corp Oh has 224,428 shares. Beese Fulmer Inv reported 58,638 shares or 0.46% of all its holdings.

More notable recent Pfizer Inc. (NYSE:PFE) news were published by: Seekingalpha.com which released: “Pfizer: The Outlook Cannot Justify Current Valuation” on August 07, 2018, also Seekingalpha.com with their article: “Pfizer: Keep On Reinvesting Dividends” published on July 24, 2018, Fool.com published: “Why Pfizer Stock Gained 10% in July” on August 06, 2018. More interesting news about Pfizer Inc. (NYSE:PFE) were released by: Fool.com and their article: “Better Buy: Johnson & Johnson vs. Pfizer” published on August 02, 2018 as well as Seekingalpha.com‘s news article titled: “Pfizer (PFE) Q2 2018 Results – Earnings Call Transcript” with publication date: July 31, 2018.

Pfizer Inc. (NYSE:PFE) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts